Leo voluntary admission: uncertified Kyntheum website pages (AUTH/3647/5/22)

📅 2022 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/3647/5/22
CompanyLeo
TypeVoluntary admission
IssueUncertified promotional material on UK promotional website pages
ProductKyntheum (brodalumab)
Material/channelPromotional website (Dermaworld) – ‘At a glance’ and ‘Mode of action’ webpages
Key job codes/pagesAt a glance tab: MAT-21384 May 2019; Mode of action tab: MAT-39266 Nov 2020 (global-approved uploaded to UK site)
Applicable Code2019
Complaint received13 May 2022
Case completed4 May 2023
Panel findingsBreach Clauses 14.1 and 9.1; No breach Clause 2
AppealNo appeal
SanctionsUndertaking received; additional sanctions not stated

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • Leo made a voluntary admission about uncertified promotional material on the Kyntheum (brodalumab) promotional website (Dermaworld).
  • Issue identified during Leo’s investigation connected to an earlier complaint/case (AUTH/3503/4/21) and subsequent PMCPA requests for further information.
  • Two UK webpages were at issue:
    • ‘At a glance’ tab (MAT-21384 May 2019): the live page differed from the certified version, including an out-of-date SPC reference (September 2017) instead of the correct SPC reference (last accessed March 2020).
    • ‘Mode of action’ tab (MAT-39266 Nov 2020): material approved for the global website (not the UK) was uploaded to the UK site by a third-party agency, meaning the UK site displayed material that had not been UK-certified.
  • Leo initially included the home tab in its voluntary admission but later withdrew that element; the Panel made no ruling on the home tab.
  • Leo stated the errors arose from third-party agency uploading mistakes; the Panel focused on Leo’s control and governance over promotional material.
⚖️

Outcome

  • Breach of Clause 14.1 (for each of the two webpages): failing to certify promotional material as required by the Code.
  • Breach of Clause 9.1: failing to maintain high standards (Panel concern that Leo did not have adequate control over promotional materials; certification underpins self-regulation).
  • No breach of Clause 2: the Panel considered the uncertified-material issue was adequately covered by the rulings under Clauses 14.1 and 9.1, and content allegations were addressed in the earlier case (AUTH/3503/4/21).
  • No ruling made on the home tab because Leo withdrew that part of the voluntary admission.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training